09:59 EDT Harpoon Therapeutics trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HARP:
- Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort
- Harpoon Therapeutics price target lowered to $40 from $80 at Canaccord
- Harpoon Therapeutics target adjusted to $7.50 from $4.50 at H.C. Wainwright
- Harpoon: AbbVie will not exercise HPN217 license option of prior deal
- Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie